| GLP-1 RA | GLP-1 receptor agonist |
| GIP | Glucose-dependent insulinotropic polypeptide |
| FDA | Food and Drug Administration |
| AHI | Apnoea–hypopnoea index |
| GLP-1 RA | GLP-1 receptor agonist |
| GIP | Glucose-dependent insulinotropic polypeptide |
| FDA | Food and Drug Administration |
| AHI | Apnoea–hypopnoea index |